These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 1465448)
21. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Fremont DH; Stura EA; Matsumura M; Peterson PA; Wilson IA Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2479-83. PubMed ID: 7708669 [TBL] [Abstract][Full Text] [Related]
23. Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide. Lybarger L; Yu YY; Miley MJ; Fremont DH; Myers N; Primeau T; Truscott SM; Connolly JM; Hansen TH J Biol Chem; 2003 Jul; 278(29):27105-11. PubMed ID: 12732632 [TBL] [Abstract][Full Text] [Related]
24. Exogenous beta 2-microglobulin is required for antigenic peptide binding to isolated class I major histocompatibility complex molecules. Kane KP; Sherman LA; Mescher MF Eur J Immunol; 1991 Sep; 21(9):2289-92. PubMed ID: 1889467 [TBL] [Abstract][Full Text] [Related]
25. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin. Achour A; Michaëlsson J; Harris RA; Ljunggren HG; Kärre K; Schneider G; Sandalova T J Mol Biol; 2006 Feb; 356(2):382-96. PubMed ID: 16375919 [TBL] [Abstract][Full Text] [Related]
26. Structural Definition of Duck Major Histocompatibility Complex Class I Molecules That Might Explain Efficient Cytotoxic T Lymphocyte Immunity to Influenza A Virus. Wu Y; Wang J; Fan S; Chen R; Liu Y; Zhang J; Yuan H; Liang R; Zhang N; Xia C J Virol; 2017 Jul; 91(14):. PubMed ID: 28490583 [TBL] [Abstract][Full Text] [Related]
27. Most residues on the floor of the antigen binding site of the class I MHC molecule H-2Kd influence peptide presentation. Jaulin C; Romero P; Luescher IF; Casanova JL; Prochnicka-Chalufour A; Langlade-Demoyen P; Maryanski JL; Kourilsky P Int Immunol; 1992 Aug; 4(8):945-53. PubMed ID: 1358191 [TBL] [Abstract][Full Text] [Related]
28. An in vitro study of the dynamic features of the major histocompatibility complex class I complex relevant to its role as a versatile peptide-receptive molecule. Hörig H; Papadopoulos NJ; Vegh Z; Palmieri E; Angeletti RH; Nathenson SG Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13826-31. PubMed ID: 9391112 [TBL] [Abstract][Full Text] [Related]
29. Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2). Androlewicz MJ; Ortmann B; van Endert PM; Spies T; Cresswell P Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12716-20. PubMed ID: 7809108 [TBL] [Abstract][Full Text] [Related]
30. The fate of the three subunits of major histocompatibility complex class I molecules. Neefjes JJ; Smit L; Gehrmann M; Ploegh HL Eur J Immunol; 1992 Jun; 22(6):1609-14. PubMed ID: 1318200 [TBL] [Abstract][Full Text] [Related]
31. Peptide interaction with a class I major histocompatibility complex-encoded molecule: allosteric control of the ternary complex stability. Gakamsky DM; Bjorkman PJ; Pecht I Biochemistry; 1996 Nov; 35(47):14841-8. PubMed ID: 8942647 [TBL] [Abstract][Full Text] [Related]
32. Preparation of stable single-chain trimers engineered with peptide, beta2 microglobulin, and MHC heavy chain. Hansen T; Yu YYL; Fremont DH Curr Protoc Immunol; 2009 Nov; Chapter 17():17.5.1-17.5.17. PubMed ID: 19918946 [TBL] [Abstract][Full Text] [Related]
33. Soluble mouse major histocompatibility complex class II molecules produced in Drosophila cells. Wallny HJ; Sollami G; Karjalainen K Eur J Immunol; 1995 May; 25(5):1262-6. PubMed ID: 7774629 [TBL] [Abstract][Full Text] [Related]
34. A mutant cell in which association of class I heavy and light chains is induced by viral peptides. Townsend A; Ohlën C; Foster L; Bastin J; Ljunggren HG; Kärre K Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 1():299-308. PubMed ID: 2484163 [TBL] [Abstract][Full Text] [Related]
35. Real-time measurement of antigenic peptide binding to empty and preloaded single-chain major histocompatibility complex class I molecules. Ojcius DM; Godeau F; Abastado JP; Casanova JL; Kourilsky P Eur J Immunol; 1993 May; 23(5):1118-24. PubMed ID: 8477806 [TBL] [Abstract][Full Text] [Related]
36. Dissociation of β2-microglobulin determines the surface quality control of major histocompatibility complex class I molecules. Montealegre S; Venugopalan V; Fritzsche S; Kulicke C; Hein Z; Springer S FASEB J; 2015 Jul; 29(7):2780-8. PubMed ID: 25782992 [TBL] [Abstract][Full Text] [Related]
37. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Wei ML; Cresswell P Nature; 1992 Apr; 356(6368):443-6. PubMed ID: 1557127 [TBL] [Abstract][Full Text] [Related]
39. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells. Mangino G; Grazia Capri M; Barnaba V; Alberti S Int J Cancer; 2002 Oct; 101(4):353-9. PubMed ID: 12209960 [TBL] [Abstract][Full Text] [Related]
40. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product. Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]